As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Biologics Market: By Source: Microbial Source, Mammalian Source, Others; By Product Type: Monoclonal Antibodies, Vaccines, Others; By Manufacturing; By Disease Category; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Biologics Market Outlook

The global biologics market is expected to grow in the forecast period of 2021-2026 at a CAGR of 4.1% to reach approximately USD 415 billion by 2026.

 

Microbial Sources to Witness a Rapid Growth Over the Forecast Period

Regionally, North America holds a significant market share owing to the presence of several major companies and subsequent heavy investments in the R&D sector. Meanwhile, a noteworthy share of key players in the Asia Pacific is likely to drive the market growth in the coming years. Since a major portion of the product range has its source in microbial expressions system, the largest share of the market is occupied by microbial sources. These are extensively used during the process of treatment of several chronic diseases depending on the type of monoclonal antibodies. Moreover, products used in cancer treatment predominantly in the oncology segment generate a significant revenue share for the monoclonal antibodies (MABs) segment.

 

Global Biologics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Biologics: Industry Definition and Segmentation

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of their components, such as blood, cells, genes, tissues, allergens, and recombinant proteins. They control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system.

On the basis of source, the market can be segmented into:

  • Microbial Source
  • Mammalian Source
  • Others

The market can be broadly categorised based on its product type into:

  • Monoclonal Antibodies
    • Murine MABs
    • Chimeric MABs
    • Humanised MABs
    • Human MABs
    • Others
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others

Based on manufacturing, the market can be segmented into:

  • Outsourced
  • In-house

The market for biologics based on disease category is divided into:

  • Oncology
  • Infectious Disease
  • Immunological Disorders
  • Cardiovascular disorders
  • Hematologic Disorders
  • Others

The regional markets for biologics include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Incidences of Chronic Diseases Likely to Boost Growth for Biologics Industry

The global market for biologics is being driven by the escalating incidences and diagnosis of chronic diseases that require improved diagnostics and treatment drugs. The evident increase in the number of cancer patients and subsequent deaths worldwide, year after year, is creating a need to modify therapies and introduce drugs, which can enhance the immune system and destroy cancer cells at the earliest possible stage. Scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biologics products.

Furthermore, government authorities, taking initiatives to promote the healthcare sector to ensure the availability of biologics, are expected to offer an additional boost to the market growth. Moreover, research and development (R&D) activities undertaken by several major companies are anticipated to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

 

Key Industry Players in the Global Biologics Market

The report presents a detailed analysis of the following key players in the global biologics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Samsung Biologics
  • Amgen Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Precision Biologics, Inc.
  • F. Hoffmann-La Roche AG
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Source, Product Type, Manufacturing, Disease Category, Region
Breakup by Source Microbial Source, Mammalian Source, Others
Breakup by Product Type Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, Others
Breakup by Manufacturing Outsourced, In-house
Breakup by Disease Category Oncology, Infectious Disease, Immunological Disorders, Cardiovascular disorders, Hematologic Disorders, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Trade Data Analysis Major Importing Countries by Value and Volume, Major Exporting Countries by Value and Volume
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., F. Hoffmann-La Roche AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Biologics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Biologics Historical Market (2016-2020) 
    8.3    Global Biologics Market Forecast (2021-2026)
    8.4    Global Biologics Market by Source
        8.4.1    Microbial Source
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Mammalian Source
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Others
    8.5    Global Biologics Market by Product Type
        8.5.1    Monoclonal Antibodies
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
                8.5.1.3.1    Murine MABs
                8.5.1.3.2    Chimeric MABs
                8.5.1.3.3    Humanised MABs
                8.5.1.3.4    Human MABs
                8.5.1.3.5    Others
        8.5.2    Vaccines    
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Recombinant Proteins
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Antisense, RNAi and Molecular Therapy
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Others
    8.6    Global Biologics Market by Manufacturing
        8.6.1    Outsourced
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    In-house
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
    8.7    Global Biologics Market by Disease Category
        8.7.1    Oncology
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Infectious Disease
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Immunological Disorders
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Cardiovascular disorders
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2016-2020)
            8.7.4.3    Forecast Trend (2021-2026)
        8.7.5    Hematologic Disorders
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2016-2020)
            8.7.5.3    Forecast Trend (2021-2026)
        8.7.6    Others
    8.8    Global Biologics Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Trade Data Analysis (3002)

    12.1    Major Exporting Countries
        12.1.1    By Value
        12.1.2    By Volume
    12.2    Major Importing Countries
        12.2.1    By Value
        12.2.2    By Volume
13    Competitive Landscape
    13.1    Market Structure
    13.2    Company Profiles
        13.2.1    Samsung Biologics
            13.2.1.1    Company Overview
            13.2.1.2    Product Portfolio
            13.2.1.3    Demographic Reach and Achievements
            13.2.1.4    Certifications
        13.2.2    Amgen Inc.
            13.2.2.1    Company Overview
            13.2.2.2    Product Portfolio
            13.2.2.3    Demographic Reach and Achievements
            13.2.2.4    Certifications
        13.2.3    Novo Nordisk A/S
            13.2.3.1    Company Overview
            13.2.3.2    Product Portfolio
            13.2.3.3    Demographic Reach and Achievements
            13.2.3.4    Certifications
        13.2.4    Pfizer Inc.
            13.2.4.1    Company Overview
            13.2.4.2    Product Portfolio
            13.2.4.3    Demographic Reach and Achievements
            13.2.4.4    Certifications
        13.2.5    Merck & Co., Inc.
            13.2.5.1    Company Overview
            13.2.5.2    Product Portfolio
            13.2.5.3    Demographic Reach and Achievements
            13.2.5.4    Certifications
        13.2.6    Precision Biologics, Inc.
            13.2.6.1    Company Overview
            13.2.6.2    Product Portfolio
            13.2.6.3    Demographic Reach and Achievements
            13.2.6.4    Certifications
        13.2.7    F. Hoffmann-La Roche AG
            13.2.7.1    Company Overview
            13.2.7.2    Product Portfolio
            13.2.7.3    Demographic Reach and Achievements
            13.2.7.4    Certifications
        13.2.8    Others
14    Industry Events and Developments

 

List of Figures and Tables

1.    Global Biologics Market: Key Industry Highlights, 2016 and 2026
2.    Global Biologics Historical Market: Breakup by Source (USD Billion), 2016-2020
3.    Global Biologics Market Forecast: Breakup by Source (USD Billion), 2021-2026
4.    Global Biologics Historical Market: Breakup by Product Type (USD Billion), 2016-2020
5.    Global Biologics Market Forecast: Breakup by Product Type (USD Billion), 2021-2026
6.    Global Biologics Historical Market: Breakup by Manufacturing (USD Billion), 2016-2020
7.    Global Biologics Market Forecast: Breakup by Manufacturing (USD Billion), 2021-2026
8.    Global Biologics Historical Market: Breakup by Disease Category (USD Billion), 2016-2020
9.    Global Biologics Market Forecast: Breakup by Disease Category (USD Billion), 2021-2026
10.    Global Biologics Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global Biologics Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America Biologics Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America Biologics Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe Biologics Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe Biologics Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific Biologics Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific Biologics Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America Biologics Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America Biologics Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa Biologics Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa Biologics Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Major Importing Countries by Volume (2020)
23.    Major Exporting Countries by Volume (2020)
24.    Major Importing Countries by Value (2020)
25.    Major Exporting Countries by Value (2020)
26.    Global Biologics Market Structure

Key Questions Answered in the Report

The global biologics market is projected to grow at a CAGR of 4.1% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 415 billion by 2026.

The market is being aided by the increasing research and development (R&D) activities and the rising demand for microbial expression systems in the treatment of various chronic diseases.

The industry is expected to be propelled by the growing prevalence of chronic diseases such as cancer, the increasing research activities to enhance the productivity of biologics products, and the robust growth of the healthcare sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major sources of biologics in the industry are microbial source, and mammalian source, among others.

The significant product types in the market are monoclonal antibodies, vaccines, recombinant proteins, and antisense, RNAi and molecular therapy, among others.

The various manufacturing segments of biologics are outsourced and in-house.

The different disease categories of biologics are oncology, infectious disease, immunological disorders, cardiovascular disorders, and hematologic disorders, among others.

The major players in the industry are Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., and F. Hoffmann-La Roche AG, among others.

Analyst Review

The global biologics market is driven by the rising demand for microbial expression systems in the treatment of various chronic diseases. Aided by the increasing research activities to enhance the productivity of biologics products, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 4.1%. The market is projected to reach about USD 415 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By sources, the market is divided into microbial source, and mammalian source, among others. Based on its product types, the biologics industry can be segmented into monoclonal antibodies, vaccines, recombinant proteins, and antisense, RNAi and molecular therapy, among others. On the basis of manufacturing, the industry is bifurcated into outsourced and in-house. By disease categories, the market is segmented into oncology, infectious disease, immunological disorders, cardiovascular disorders, and hematologic disorders, among others. The major regional markets for biologics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Samsung Biologics, Amgen Inc., Novo Nordisk A/S, Pfizer Inc., Merck & Co., Inc., Precision Biologics, Inc., and F. Hoffmann-La Roche AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER